Patients that were 40–49 years of age had the highest percentage of ICS/LABA use (80.9%; n = 114/141) relative to other age groups, while the percentage of patients using open triple therapy generally showed an increasing trend with age ( Figure 3A ).
← all excerpts
Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database.
1
—
—